Didymocalyxin B



Compound IDCDAMM01049
Common nameDidymocalyxin B
IUPAC name1-[2,6-dihydroxy-4,5-dimethoxy-7-(3-phenylprop-2-enoyl)-1-benzofuran-3-yl]-3-phenylprop-2-en-1-one
Molecular formulaC28H22O7

Experimental data

Retention time0.29
Adduct[M+H]+
Actual mz471.146
Theoretical mz471.144
Error3.02
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.957

Identifiers and class information

Inchi keySYJASFPLLHXQRX-VZZMMMTHSA-N
SmilesO=C1OC=2C(C(=O)C=CC=3C=CC=CC3)=C(O)C(OC)=C(OC)C2C1=C(O)C=CC=4C=CC=CC4
SuperclassPhenylpropanoids and polyketides
ClassLinear 1,3-diarylpropanoids

Pharmacokinetic properties

Number of descriptor values(#stars)2
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)12
Number of reactive functional groups (#rtvFG)2
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)470.478
Computed dipole moment(dipole)7.197
Total solvent accessible surface area (SASA)800.126
Hydrophobic component of SASA (FOSA)189.548
Hydrophilic component of SASA (FISA)140.676
Pie component of the SASA (PISA)469.901
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1439.41
Number of hydrogen bond donors (donorHB)0
Number of hydrogen bond acceptors (accptHB)4.75
Free energy of solvation of dipole (dip^2/V)0.0359863
Index of cohesive interaction in solids (ACxDN^.5/SA)0
Globularity descriptor (glob)0.770542
Predicted polarizability in cubic angstroms (QPpolrz)48.233
Predicted hexadecane/gas partition coefficient (QPlogPC16)16.086
Predicted octanol/gas partition coefficient (QPlogPoct)19.125
Predicted water/gas partition coefficient (QPlogPw)7.829
Predicted octanol/water partition coefficient (QPlogPo/w)5.949
Predicted aqueous solubility (QPlogS)-6.939
Conformation-independent predicted aqueous solubility (CIQPlogS)-8.12
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-7.486
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)459.056
Predicted brain/blood partition coefficient (QPlogBB)-1.739
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)213.239
Predicted skin permeability, log Kp (QPlogKp)-1.305
PM3 calculated ionization potential (IP(ev))8.483
PM3 calculated electron affinity (EA(eV))0.98
Number of likely metabolic reactions (#metab)5
Prediction of binding to human serum albumin (QPlogKhsa)1.016
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)96.463
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)109.516
Number of nitrogen and oxygen atoms (#NandO)7
Number of violations of Lipinski’s rule of five (RuleOfFive)1
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P27338MAOBMonoamine oxidase BT83011SEA
P08183ABCB1P-glycoprotein 1T25258SEA
P20839IMPDH1Inosine-5'-monophosphate dehydrogenase 1T40111SEA
P12268IMPDH2Inosine-5'-monophosphate dehydrogenase 2T89360SEA
Q9UNQ0ABCG2ATP-binding cassette sub-family G member 2T56556SEA
P22001KCNA3Voltage-gated potassium channel subunit Kv1.3T76914SwissTargetPrediction and SEA
Q16678CYP1B1Cytochrome P450 1B1T92521SEA
P19438TNFRSF1ATumor necrosis factor receptor R1T86552SEA
Q13332PTPRSReceptor-type tyrosine-protein phosphatase ST10147SEA
O75884RBBP9Putative hydrolase RBBP9T12084SEA
Q9H4B7TUBB1Tubulin beta-1 chainT84397SEA
O43826SLC37A4Glucose-6-phosphate translocaseT47306SEA
P16220CREB1Cyclic AMP-responsive element-binding proteinT92098SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T83011DI0115Dementia[ICD-11: 6D80-6D8Z]P27338MAOB
T83011DI0117Depression[ICD-11: 6A70-6A7Z]P27338MAOB
T83011DI0190Hypertension[ICD-11: BA00-BA04]P27338MAOB
T83011DI0243Malaria[ICD-11: 1F40-1F45]P27338MAOB
T83011DI0264Migraine[ICD-11: 8A80]P27338MAOB
T83011DI0331Parkinsonism[ICD-11: 8A00]P27338MAOB
T25258DI0238Lung cancer[ICD-11: 2C25]P08183ABCB1
T40111DI0062Breast cancer[ICD-11: 2C60-2C6Y]P20839IMPDH1
T40111DI0179Hepatitis virus infection[ICD-11: 1E50-1E51]P20839IMPDH1
T40111DI0250Mature B-cell lymphoma[ICD-11: 2A85]P20839IMPDH1
T40111DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P20839IMPDH1
T40111DI0413Transplant rejection[ICD-11: NE84]P20839IMPDH1
T89360DI0413Transplant rejection[ICD-11: NE84]P12268IMPDH2
T56556DI0218Irritable bowel syndrome[ICD-11: DD91]Q9UNQ0ABCG2
T56556DI0366Rheumatoid arthritis[ICD-11: FA20]Q9UNQ0ABCG2
T76914DI0198Idiopathic inflammatory myopathy[ICD-11: 4A41]P22001KCNA3
T76914DI0351Psoriasis[ICD-11: EA90]P22001KCNA3
T76914DI0352Psoriatic arthritis[ICD-11: FA21]P22001KCNA3
T86552DI0060Brain cancer[ICD-11: 2A00]P19438TNFRSF1A
T86552DI0321Ovarian cancer[ICD-11: 2C73]P19438TNFRSF1A
T10147DI0057Bone paget disease[ICD-11: FB85]Q13332PTPRS
T84397DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]Q9H4B7TUBB1

Copyright © 2025